Literature DB >> 35021293

Comments on "CSF-Confirmed SARS-CoV-2 Acute Encephalitis": SARS-CoV-2-Associated Encephalitis Is Autoimmune Rather Than Infectious.

Josef Finsterer1, Fulvio Alexandre Scorza2, Ana Claudia Fiorini3.   

Abstract

Entities:  

Year:  2022        PMID: 35021293      PMCID: PMC8762503          DOI: 10.3988/jcn.2022.18.1.102

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


× No keyword cloud information.
Dear Editor, With interest we read the article by Tee et al.1 about a 69-year-old male with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated encephalitis classified as infectious upon confirmation of the virus in the cerebrospinal fluid (CSF) by PCR. The patient benefited significantly from ceftriaxone, meropenem, favipiravir, dexamethasone, methylprednisolone, clonazepam, valproic acid, and tuberculostatics.1 Complete recovery was achieved 10 days after the onset of the neurological compromise.1 The study results are appealing, but they raise several comments and concerns, as detailed below. One serious limitation of the study report is that reference limits for blood and CSF parameters were not provided, which greatly impedes the ability to interpret the results. According to our own laboratory, a cycle threshold of 36.08 for the CSF PCR is normal and does not prove infectivity. Thus, based on the study results, the diagnosis of infectious encephalitis due to infection with SARS-CoV-2 remains unproven. Another limitation is that “results of other CSF analyses” were not specified.1 It should be reported if investigations for viruses other than SARS-CoV-2 in the CSF were truly negative, if tuberculous meningitis and immune encephalitis were appropriately excluded, and if the CSF was tested for antibodies associated with immune encephalitis. Excluding immune encephalitis is crucial since SARS-CoV-2-associated encephalitis is due to an immune reaction against the virus rather than to a direct viral attack against the central nervous system.2 Moreover, recovery under steroids suggests immune encephalitis rather than infectious encephalitis. Virostatics are usually ineffective against COVID-19. A further argument for an immune mechanism is that most of the patients with SARS-CoV-2-associated encephalitis were pathophysiologically classified as autoimmune (Table 1). However, in several cases encephalitis was classified as infectious despite the virus not being reported in the CSF. Though the absence of the virus in the CSF does not generally exclude an infectious pathomechanism, it does make it rather unlikely.
Table 1

Selection of patients with SARS-CoV-2-associated infectious/autoimmune encephalitis

Age (yr)SexCSFposTypeEReference
69mEquivocalEquivocalTee et al.1
24mYesInfectiousMoriguchi et al.9
31mYesInfectiousKamal et al.10
41mYesInfectiousLuis et al.4
25fYesInfectiousLuis et al.4
3mYesInfectiousCheraghali et al.5
13fNoInfectiousNatarajan et al.11
11mNoInfectiousMcAbee et al.12
52mNoInfectiousLozano Gómez et al.13
70mNoInfectiousLozano Gómez et al.13
41fNoEquivocalDuong et al.6
69mNoEquivocalChaumont et al.14
5fNoEquivocalSiracusa et al.15
56mNoAutoimmuneParnasa et al.16
49fNoAutoimmuneGunawardhana et al.17
44fNoAutoimmuneDyachenko et al.18
43fNoAutoimmuneVazquez-Guevara et al.19
31mNoAutoimmuneJeanneret et al.20
1fNoAutoimmuneBurr et al.21
8mNoAutoimmuneAbdel-Mannan et al.22
9mNoAutoimmuneAbdel-Mannan et al.22
31fNoAutoimmuneBenameur et al.23
64mNoAutoimmuneBenameur et al.23
34mNoAutoimmuneBenameur et al.23
40fNoAutoimmuneTiraboschi et al.3
90fNoAutoimmuneLv et al.2
36mNoAutoimmuneMiqdad et al.24
18fNoAutoimmuneAllahyari et al.25

CSFpos, CSF PCR positive for SARS-CoV-2; f, female; m, male; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TypeE, type of encephalitis.

A further limitation is that cerebral magnetic resonance imaging (MRI) was not performed on admission. Encephalitis can usually be confirmed on T1-weighted images after administering gadolinium, by the presence of various degrees of focal or global enhancement. MRI performed 1 month after presentation will not reflect the acute disease. Additionally, fluorodeoxyglucose positron-emission tomography may show hypermetabolism within affected areas.3 Several other cases of SARS-CoV-2-associated infectious encephalitis reported in the literature45 were not listed in the table of the case report.1 We do not agree that the case reported by Duong et al.6 can be classified as infectious encephalitis, since the presence of the virus could not be confirmed in that particular case. A comprehensive workup of the CSF, including a cytokine profile, was also missing. In particular, interleukin (IL)-8, IL-6, IL-1b, and tumor necrosis factor-alpha can be elevated in the CSF of patients with SARS-CoV-2-associated encephalitis or myelitis.78 In summary, the study of Tee et al.1 has several limitations that challenge the reported results and their interpretation. The reported diagnosis of infectious encephalitis remains unproven, with the beneficial effect of steroids instead suggesting an autoimmune pathogenesis. Inflammatory cytokines should be measured in the CSF, which may reveal the immunological pathogenesis of SARS-CoV-2-associated encephalitis.
  24 in total

1.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.

Authors:  Takeshi Moriguchi; Norikazu Harii; Junko Goto; Daiki Harada; Hisanori Sugawara; Junichi Takamino; Masateru Ueno; Hiroki Sakata; Kengo Kondo; Natsuhiko Myose; Atsuhito Nakao; Masayuki Takeda; Hirotaka Haro; Osamu Inoue; Katsue Suzuki-Inoue; Kayo Kubokawa; Shinji Ogihara; Tomoyuki Sasaki; Hiroyuki Kinouchi; Hiroyuki Kojin; Masami Ito; Hiroshi Onishi; Tatsuya Shimizu; Yu Sasaki; Nobuyuki Enomoto; Hiroshi Ishihara; Shiomi Furuya; Tomoko Yamamoto; Shinji Shimada
Journal:  Int J Infect Dis       Date:  2020-04-03       Impact factor: 3.623

2.  SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.

Authors:  Andrea Pilotto; Stefano Masciocchi; Irene Volonghi; Valeria De Giuli; Francesca Caprioli; Sara Mariotto; Sergio Ferrari; Silvia Bozzetti; Alberto Imarisio; Barbara Risi; Enrico Premi; Alberto Benussi; Emanuele Focà; Francesco Castelli; Gianluigi Zanusso; Salvatore Monaco; Paola Stefanelli; Roberto Gasparotti; Anastasia Zekeridou; Andrew McKeon; Nicholas J Ashton; Kaj Blennov; Henrik Zetterberg; Alessandro Padovani
Journal:  Clin Infect Dis       Date:  2021-01-04       Impact factor: 9.079

3.  Case Report: Detection of SARS-CoV-2 From Cerebrospinal Fluid in a 34-Month-Old Child With Encephalitis.

Authors:  Fatemeh Cheraghali; Alireza Tahamtan; Seyed Ahmad Hosseini; Mohammad Hadi Gharib; Abdolvahab Moradi; Hadi Razavi Nikoo; Alijan Tabarraei
Journal:  Front Pediatr       Date:  2021-04-20       Impact factor: 3.418

4.  A case report of simultaneous autoimmune and COVID-19 encephalitis.

Authors:  Fakhri Allahyari; Ramin Hosseinzadeh; Javad Hosseini Nejad; Mohammad Heiat; Reza Ranjbar
Journal:  J Neurovirol       Date:  2021-04-26       Impact factor: 3.739

5.  SARS-CoV- 2 Encephalitis in an Adolescent Girl.

Authors:  Suresh Natarajan; R Ganesh; Nataraj Palaniappan; Lakshminarayanan Kannan
Journal:  Indian Pediatr       Date:  2020-12-15       Impact factor: 1.411

6.  Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review.

Authors:  Valerie Jeanneret; Daniel Winkel; Aida Risman; Hang Shi; Grace Gombolay
Journal:  J Neuroimmunol       Date:  2021-05-29       Impact factor: 3.478

7.  Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020.

Authors:  Lisa Duong; Prissilla Xu; Antonio Liu
Journal:  Brain Behav Immun       Date:  2020-04-17       Impact factor: 7.217

8.  N-Methyl-d-Aspartate Receptor Encephalitis Associated With COVID-19 Infection in a Toddler.

Authors:  Tyler Burr; Christopher Barton; Elizabeth Doll; Arpita Lakhotia; Michael Sweeney
Journal:  Pediatr Neurol       Date:  2020-10-09       Impact factor: 3.372

9.  Postinfectious Neurologic Complications in COVID-19: A Complex Case Report.

Authors:  Pietro Tiraboschi; Rubjona Xhani; Simone M Zerbi; Angelo Corso; Isabella Martinelli; Laura Fusi; Giampiero Grampa; Andrea Lombardo; Paola Cavalcante; Cristina Cappelletti; Francesca Andreetta; Alberto Sironi; Alberto Redolfi; Cristina Muscio
Journal:  J Nucl Med       Date:  2021-05-20       Impact factor: 10.057

10.  Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report.

Authors:  Champika Gunawardhana; Geetha Nanayakkara; Dhanusha Gamage; Indika Withanage; Manjeewa Bandara; Chandima Siriwimala; Nipun Senaratne; Thashi Chang
Journal:  Neurol Sci       Date:  2021-06-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.